Pharmaceuticals, Biotechnology and Life Sciences
Venatorx Pharmaceuticals has teamed up with GARDP to develop antibiotics for hospital-acquired infections, which comes at a critical time with a study showing bacterial infections present in half of the deceased COVID-19 patients.
VenatoRx Pharmaceuticals today announced that Joseph C. Larsen, Ph.D. has joined the Company as Vice President, Strategic Portfolio Development. With more than 20 years’ experience, Dr. Larsen is globally recognized as a leader in the area of public health preparedness. At VenatoRx, Dr. Larsen will help translate VenatoRx’s rich internal programs toward strategic public and private partnerships, and will help identify new growth opportunities for VenatoRx.
MALVERN, Pa.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/antibiotics?src=hash" target="_blank"gt;#antibioticslt;/agt;–VenatoRx Pharmaceuticals today announced that Lisa Wittmer, Ph.D. has joined the Company as Chief Development Officer.…